Recently, Zhengcong Technology (Shanghai) Co., Ltd. (abbreviation: Zhengcong Technology) announced the completion of an angel round of financing of tens of millions of yuan. This round of financing was exclusively invested by Furong Capital. The financing will continue to be used for new product research and development, team building and market expansion at home and abroad.
It is understood that Zhengcong Technology was established in 2020, focusing on the development and manufacture of automation equipment and flexible automation products for the field of life sciences, and providing customers in this field with more standardized, precise and efficient improvement solutions.
Recently, Zhengcong Technology officially launched a fully automatic solid medicine weighing and adding sampler, and realized an intelligent manufacturing team for large-scale mass production. It is reported that Zhengcong Technology’s fully automatic sampling instrument can accurately weigh and add more than 100 kinds of solid medicines with different properties within one hour, and there is no need to clean the equipment when switching medicines. The weighing range is between 1 mg and 200 grams. Accuracy up to 0.1 mg. At present, this brand-new fully automatic sampler is being delivered in batches to many enterprises in the field of life sciences.
In addition to standardized instruments and equipment, the flexible automation robot products and overall solutions that are being designed and manufactured by Science and Technology have also been successfully delivered to many customers in the field of life sciences. Among them, the mobile composite robot is used as the medium to connect all the equipment from the perspective of automation without replacing the existing expensive instruments and equipment, and then realize the connection of sample flow, control flow and data flow, and fully upgrade the traditional laboratory to unmanned automation. laboratory. With this automated system that can independently complete hundreds of experiments (including experimental operations, data collection and analysis) 7*24 hours a day, the laboratory can free up 3-5 operators, improve research and development efficiency, and improve experimental performance. degree of standardization.
At present, Zhengcong Technology is building a product matrix with automated precision instruments, mobile composite robot platforms and high-throughput mechanical equipment as the core, transforming common requirements into standardized products and realizing mass production.
Dr. Wu Junwei, the founder and CEO of Zhengcong Technology, said: “The vision of Zhengcong Technology is to help humans do experiments faster and better. At the same time, we also hope to position ourselves as a practitioner of domestic substitution or even domestic excellence, and will continue to focus on deep cultivation. Biomedicine, robotics, artificial intelligence and other hard science and technology fields that the country focuses on. The reason why we have been insisting on positive research and development is that we have seen the bottleneck of quickly borrowing foreign technology in the past. We must firmly grasp independent core technology and integrate key technologies To achieve the world’s leading level. From the perspective of technology, we hope to work with colleagues from all walks of life to make unremitting efforts to upgrade made in China to made by China and designed by China.”
Talking about the logic of this investment, Dr. Sun Pengjun, chairman of Furong Investment, said: “When life science research and development gradually enters the deep water area, more and more attention is paid to the quality of early research and original basic research and development, and the problem of low efficiency in laboratories and production has become increasingly prominent. , especially in many high-throughput repetitive experimental actions, which are still completed by highly educated and high-quality talents in many cases. Furong Capital has been looking for an automation company, which is not a pure integrator or customized service provider. It needs to have strong development capabilities to solve actual pain points in products, so choosing Zhengcong Technology is our answer, and we hope that Zhengcong Technology will make rapid progress on the road to becoming a full-stack automation solution provider in the field of life sciences.”
media reports
Arterial Network Arterial Network Entrepreneurship State
related events
- “Zhengcong Technology” has completed tens of millions of yuan in angel round financing, and Furong Capital is the exclusive investment2023-01-03
- Leo Science completes tens of millions of RMB angel round financing2022-12-05
- Qingyuan Kaiwu completes tens of millions of yuan in angel round financing2022-08-01
- Mega completed the C-round financing of US$ 300 million2022-06-15
- Laboratory automation company Sage Scientific Group received over 100 million yuan in Series A financing2022-06-14
This article is transferred from: https://readhub.cn/topic/8mgzxpIbg0a
This site is only for collection, and the copyright belongs to the original author.